ViagrON 100 mg/tab – US Stock
$17.24
ViagrON 100 mg/tab is an oral tablet formulation containing sildenafil, a PDE5 inhibitor. Each tablet contains 100 mg of active ingredient, with 10 tablets per pack and a stated active half-life of approximately 4 hours. Manufactured by Hilma Biocare and listed as US Stock.
ViagrON 100 mg/tab – US Stock
ViagrON 100 mg/tab from Hilma Biocare is an oral tablet formulation containing sildenafil, a phosphodiesterase type 5 (PDE5) inhibitor. Each tablet contains 100 mg of sildenafil, and the product is supplied in a 10-tablet pack.
Product Overview
Sildenafil belongs to the PDE5 inhibitor class and is a pharmacologically active compound associated with vascular smooth-muscle effects and increased blood flow. The supplied product description identifies ViagrON in connection with sexual function and describes additional blood-flow-related effects.
The product specifications state an active half-life of approximately 4 hours. ViagrON is supplied as an oral tablet and is specified as having no water retention or aromatization.
Active Ingredient
The active ingredient is Sildenafil, a PDE5 inhibitor.
Dosage Form and Strength
ViagrON is supplied as an oral tablet containing 100 mg of sildenafil per tablet.
Product Characteristics
According to the supplied specifications, ViagrON has the following characteristics:
- Oral tablet formulation
- 100 mg sildenafil per tablet
- Approximately 4-hour active half-life
- PDE5 inhibitor classification
- 10 tablets per pack
- No water retention listed
- No aromatization listed
Product Specifications
| Specification | Details |
|---|---|
| Brand | Hilma Biocare |
| Product Name | ViagrON |
| Active Ingredient | Sildenafil |
| Group | PDE5 inhibitor |
| Form | Oral tablet |
| Strength | 100 mg per tablet |
| Active Half-Life | Approximately 4 hours |
| Pack Size | 10 tablets |
| Water Retention | No, according to supplied specifications |
| Aromatization | No, according to supplied specifications |
| Stock | US Stock |
Product Characteristics
Sildenafil is a PDE5 inhibitor associated with vascular effects and increased blood flow. The supplied description discusses ViagrON primarily in relation to sexual function and also describes its use among athletes in connection with circulation and workout-related effects.
Performance-related statements in the source material should not be interpreted as established athletic benefits or guarantees of improved exercise performance. The product should be evaluated based on its pharmacological properties and approved medical information.
Reported Side Effects
The supplied product information identifies several possible adverse effects associated with ViagrON, including:
- Headache
- Chest pain
- Dizziness
- Upset stomach
- Blurred vision
- Nasal congestion
- Facial redness
Sildenafil can affect blood pressure and cardiovascular function. Individuals should consult an appropriately qualified healthcare professional regarding contraindications, medication interactions, and suitability before use.
Important Information
ViagrON contains sildenafil, a pharmacologically active PDE5 inhibitor. The information on this page is provided for product identification and factual specification purposes only and does not constitute personalized medical advice.
No dosing recommendations, treatment protocols, or instructions for self-administration are provided. The supplied information states that ViagrON should not be combined with other PDE5 inhibitors; potential interactions with blood-pressure medications and other medicines should be evaluated by a healthcare professional.
About Hilma Biocare USA
ViagrON 100 mg/tab is part of the Hilma Biocare product range. Each tablet contains 100 mg of sildenafil, and the product is supplied in a 10-tablet pack with a stated active half-life of approximately 4 hours, listed as US Stock.
Reviews
There are no reviews yet.